{
    "2018-09-25": [
        [
            {
                "time": "2018-09-24",
                "original_text": "Elanco Animal Health IPO",
                "features": {
                    "keywords": [
                        "Elanco",
                        "IPO",
                        "Animal Health"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-25",
                "original_text": "A Brief Bird's Eye View of Fresh IPO Elanco Animal Health",
                "features": {
                    "keywords": [
                        "Elanco",
                        "IPO",
                        "Fresh"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Allerganâ€™s Stock Price Performance in September",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Stock Price",
                        "September"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "J&J's Esketamine Fails to Meet Endpoint in Phase III Study",
                "features": {
                    "keywords": [
                        "J&J",
                        "Esketamine",
                        "Phase III",
                        "Study",
                        "Fails"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}